Name Net closed
positions
Closed positions New positions Return since
30 Sep ‘23
276
4 8 4 90.6%
277
4 7 3 274%
278
4 7 3 51.2%
SABS icon
279
SAB Biotherapeutics
SABS
$247M
4 7 3 44.1%
280
4 7 3 12.9%
281
4 7 3 72.4%
282
4 7 3 34.4%
283
4 7 3 92.1%
284
4 7 3 16.2%
285
4 6 2 33.3%
NXTC icon
286
NextCure
NXTC
$37.5M
4 6 2 32%
287
4 6 2 113%
288
4 6 2 38.5%
289
4 6 2 17%
290
4 6 2 41.9%
291
4 6 2 97.8%
292
4 6 2 57.5%
293
4 6 2 54%
294
4 5 1 88.7%
295
4 5 1 99.5%
296
4 5 1 33.2%
297
4 5 1 98.5%
298
4 5 1 71.7%
299
4 5 1 31%
300
4 5 1 82.1%